Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization

Area of Science:

• Cardiovascular Research
• Myocardial Pathophysiology
• Biochemistry

Background:

• Coronary microembolization can lead to myocardial dysfunction.
• The precise molecular mechanisms underlying this dysfunction, particularly at the myofibrillar protein level, require further elucidation.

Purpose of the Study:

• To investigate the role of myofibrillar protein oxidation, specifically disulfide cross-bridge (DCB) formation in tropomyosin, as a mechanism for myocardial dysfunction after coronary microembolization.

Main Methods:

• Induction of coronary microembolization using microspheres in anesthetized pigs and dogs.
• Assessment of systolic wall thickening, tropomyosin DCB formation, and TNF-alpha content.
• In vitro analysis using dithiothreitol and in vivo intervention with ascorbic acid.

Main Results:

• Microembolized areas showed significantly reduced systolic wall thickening and increased tropomyosin DCB formation.
• Impaired contractile function correlated inversely with DCB formation and was associated with increased TNF-alpha.
• Ascorbic acid administration prevented contractile dysfunction and associated molecular changes.

Conclusions:

• Myofibrillar protein oxidation, evidenced by increased DCB in tropomyosin, is a key mechanism linking inflammation to contractile dysfunction post-coronary microembolization.
• Targeting oxidative stress, such as with ascorbic acid, may offer therapeutic potential for microembolization-induced myocardial injury.